Search

everythinglearnresearchcommunity

for

Search:↓

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

A new accurate and reliable method was developed to measure Spironolactone and Hydrochlorothiazide together in medicines.

ALUDWIG can help standardize female hair loss assessment from a single image.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

RY-023, a specific drug, can improve early stage memory learning without affecting general activity in rats, but it's less effective for later learning stages and doesn't impact memory recall.

Early diagnosis of leprosy is crucial to prevent disabilities and spread, even in non-endemic areas.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

Lygodii Spora extract may help treat hair loss by blocking a hair loss-related enzyme and promoting hair growth.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

Lotus corniculatus seed extract reduces oily skin by decreasing sebum production.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Baricitinib and its combination with lonafarnib improve fat cell formation in certain genetic disorders.

The method is quick and effective for testing steroid 5 alpha-reductase inhibitors.

The quality of Neelibhringadi Keratailam varies among products, suggesting a need for better standardization and quality control.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

The Hair660™ light therapy device effectively and safely improves hair density in people with androgenetic alopecia.

The document's conclusion cannot be provided because the document is not accessible or understandable.

The updated criteria improve the accuracy of diagnosing lupus.

The IBHRS is now operational.